Etodolac Tablet, Film Coated, Extended Release
Product Images NDC 63187-374

2 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 63187-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Etodolac Extended-release Tablets, Usp (Etodolacertablets Figure 01)

Etodolac Extended-release Tablets, Usp (Etodolacertablets Figure 01)
Chemical structure of Etodolac, showing its molecular framework including a fused ring system with a carboxyl group and ethyl substituents.*
FDA Label Image

63187-374-30 (Etodolacertablets Figure 04)

63187-374-30 (Etodolacertablets Figure 04)
Label for Etodolac 400 mg extended-release (ER) film-coated tablets by Proficient Rx LP. The label shows a quantity of 30 tablets, with directions to dispense the medication guide separately. Tablets are described as orange-colored, oval, beveled, film-coated, debossed with '271' on one side, plain on the other. Manufactured by Cadila Healthcare Ltd., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.